A year after NICE issued guidance on the management of Generalised Anxiety Disorder (GAD) highlighting that the condition was under-treated and under-detected, a new survey shows that GPs believe that this is still the case. Results from the survey of 308 GPs commissioned by Pfizer show that GAD continues to be a challenge, with over a third of GPs (38%) admitting they are either somewhat, or not that confident, in diagnosing GAD. Furthermore only 49% of GPs feel comfortable distinguishing GAD from other mental health disorders. This is despite the condition being one of the most common psychiatric disorders seen in primary care, affecting approximately one in 20 adults in Britain. In follow up research involving 135 GPs, nearly three quarters (72%) of those surveyed believe GAD is under diagnosed. These findings reflect NICE guidance, issued last year, which states that GP rates of diagnosis and treatment of anxiety disorders are much lower than expected from the prevalence figures, showing there is still a need for improvement. Dr Henk Parmentier, a GP from South London with a special interest in GAD, commented: “Although common and treatable, GAD can be extremely challenging to diagnose as it manifests in a complex combination of psychological and physical symptoms, in addition to frequent comorbid conditions and so patients rarely present with pure anxiety.”